Karyopharm Therapeutics Inc (NAS:KPTI)
$ 9.62 +0.020 (+0.21%) Market Cap: 218.02 Mil Enterprise Value: 358.04 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 52/100

Karyopharm Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 07:35 PM GMT
Release Date Price: $7.47 (+4.62%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KPTI.OQ - Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc at RBC Capital Markets Global Healthcare Conference
May 19, 2026 / 07:35PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Therapeutics, represented by their President and CEO, Richard Paulson, and their CMO, Reshma Rangwala.

Richard and Reshma, thank you guys so much for being here.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you for having us, Brian.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
There's a lot of data we're going to be looking for in the coming months. So let's dive
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot